Evidence map›Paper›PMID 31726031›Full record

ArticleCell host & microbe2019

A Listeria monocytogenes Bacteriocin Can Target the Commensal Prevotella copri and Modulate Intestinal Infection.

Nathalie Rolhion, Benoit Chassaing, Marie-Anne Nahori, Jana de Bodt, Alexandra Moura, Marc Lecuit, Olivier Dussurget, Marion Bérard, Massimo Marzorati, Hannah Fehlner-Peach and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. The OMMGut microbes · 2026
    Review
  3. Review
  4. Review
  5. Impact of the defined Oligo-MMScientific reports · 2026
    Article
  6. Article
  7. Review
  8. ComparingGut microbes · 2025
    Article
  9. Listeriosis.Nature reviews. Disease primers · 2025
    Review
  10. Article
  11. Preparation ofLife (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Exploring the fate ofFrontiers in microbiology · 2025
    Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Nathalie RolhionInstitut Pasteur, Unité des Interactions Bactéries-Cellules, 75015 Paris, France; Inserm, U604, 75015 Paris, France; INRA, Unité sous-contrat 2020, 75015 Paris, France.
Benoit ChassaingNeurosciences Institute, Georgia State University (GSU), Atlanta, GA 30303, USA; Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, GSU, Atlanta, GA 30303, USA.
Marie-Anne NahoriInstitut Pasteur, Unité des Interactions Bactéries-Cellules, 75015 Paris, France; Inserm, U604, 75015 Paris, France; INRA, Unité sous-contrat 2020, 75015 Paris, France.
Jana de BodtCenter of Microbial Ecology and Technology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium.
Alexandra MouraInstitut Pasteur, Unité Biologie des Infections, 75015 Paris, France; Inserm, U1117, 75015 Paris, France.
Marc LecuitInstitut Pasteur, Unité Biologie des Infections, 75015 Paris, France; Inserm, U1117, 75015 Paris, France; Paris Descartes University, Sorbonne Paris Cité, Division of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, Institut Imagine, 75743 Paris, France.
Olivier DussurgetInstitut Pasteur, Unité des Interactions Bactéries-Cellules, 75015 Paris, France; Inserm, U604, 75015 Paris, France; INRA, Unité sous-contrat 2020, 75015 Paris, France; Université de Paris, 75013 Paris, France.
Marion BérardAnimalerie Centrale, Department of Technology and Scientific Programmes, Institut Pasteur, 75015 Paris, France.
Massimo MarzoratiCenter of Microbial Ecology and Technology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium.
Hannah Fehlner-PeachThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Dan R LittmanThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA; Howard Hughes Medical Institute, New York, NY 10016, USA.
Andrew T GewirtzCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, GSU, Atlanta, GA 30303, USA.
Tom Van de WieleCenter of Microbial Ecology and Technology, Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium.
Pascale CossartInstitut Pasteur, Unité des Interactions Bactéries-Cellules, 75015 Paris, France; Inserm, U604, 75015 Paris, France; INRA, Unité sous-contrat 2020, 75015 Paris, France. Electronic address: pascale.cossart@pasteur.fr.
Inserm · FRGhent University · BEInstitut Pasteur · FRGeorgia State University · USHoward Hughes Medical Institute · USNew York University · US

Funding

NRSA Training CoreTL1TR001447 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICOLI, KEITH J. · 2015 to 2025
$5.9M
Howard Hughes Medical InstituteNCATS NIH HHS TL1 TR001447
6 · The paper itself

Abstract

Understanding the role of the microbiota components in either preventing or favoring enteric infections is critical. Here, we report the discovery of a Listeria bacteriocin, Lmo2776, which limits Listeria intestinal colonization. Oral infection of conventional mice with a Δlmo2776 mutant leads to a thinner intestinal mucus layer and higher Listeria loads both in the intestinal content and deeper tissues compared to WT Listeria. This latter difference is microbiota dependent, as it is not observed in germ-free mice. Strikingly, it is phenocopied by pre-colonization of germ-free mice before Listeria infection with Prevotella copri, an abundant gut-commensal bacteria, but not with the other commensals tested. We further show that Lmo2776 targets P. copri and reduces its abundance. Together, these data unveil a role for P.copri in exacerbating intestinal infection, highlighting that pathogens such as Listeria may selectively deplete microbiota bacterial species to avoid excessive inflammation.

Indexed as

AnimalsAnti-Bacterial AgentsBacteriocinsFemaleGastrointestinal MicrobiomeGerm-Free LifeHumansInflammationListeria monocytogenesListeriosisMiceMice, Inbred BALB CMice, Inbred C57BLPrevotellaAnti-Bacterial AgentsBacteriocinsBacteriocininfectionListeria monocytogenesLmo2776microbiotaM-SHIMEPrevotella copri

Identifiers

PMID31726031
PMCPMC6854461
OpenAlexW2982927910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.